Relationship between blood pressure, cholesterolemia and serum apolipoprotein B in a large population sample
Authors:
- Arrigo F.G. CiceroACArrigo F.G. Cicero
- Sergio D’addatoSDSergio D’addato
- Maddalena VeronesiMVMaddalena Veronesi
- Martina RosticciMRMartina Rosticci
- Francesca SantiFSFrancesca Santi
- Ada DormiADAda Dormi
- Claudio BorghiCBClaudio Borghi
- 1 March 2012
- journal article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 30 (3) , 492-496
Abstract
The objective is to evaluate the relationship between cholesterolemia, serum apolipoprotein B (apoB) level and blood pressure in a large sample of general population. The Brisighella Heart Study (BHS) is a prospective, population-based longitudinal epidemiological investigation. For this study, we analysed the data sampled in the 2008 BHS population survey, excluding those participants treated with antihypertensive and/or lipid lowering drugs (N: 2473). In a sex, BMI, smoking habit, physical activity level and serum creatinine adjusted model, low-density lipoprotein-cholesterol (LDL-C) appears to be significantly related to SBP (P < 0.001), DBP (P = 0.026), and pulse pressure (PP) (P < 0.001). In individuals aged less than 52 years, LDL-C was significantly associated to SBP and DBP (P < 0.001), but not PP. In the same model, apoB appears to be mildly but significantly related to SBP (P < 0.001), DBP (P < 0.001), and PP (P < 0.001). In individuals aged less than 52 years, apoB was significantly associated to SBP (P < 0.001), DBP (P < 0.001), and PP (P < 0.001). In individuals aged 52 or more, nor LDL-C neither apoB were significantly associated to blood pressure. Including in the same model LDL-C and apoB, apoB excluded the predicting role of LDL-C as it regards the blood pressure either in the whole population sample and in the younger individuals. On the basis of our observation, either serum LDL-C and apoB are significantly related to the blood pressure level in a large sample of individuals untreated with antihypertensive and lipid-lowering drugs. This association is stronger in younger individuals than in elderly. ApoB seems to be a stronger predictor of either SBP, DBP and PP than LDL-C.Keywords
This publication has 18 references indexed in Scilit:
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular RiskCirculation: Cardiovascular Quality and Outcomes, 2011
- Prevalence of Hyperapolipoprotein B and Associations with Other Cardiovascular Risk Factors Among Human Immunodeficiency Virus–Infected Patients in Pernambuco, BrazilMetabolic Syndrome and Related Disorders, 2010
- Detection of familial combined hyperlipoproteinaemia patients in the Brisighella Heart Study historical cohort: An epidemiological approachJournal of Inherited Metabolic Disease, 2007
- Associations of apolipoprotein B with pulse pressure and glucose in Chinese families with familial combined hyperlipidemiaInternational Journal of Cardiology, 2007
- Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studiesNutrition, Metabolism and Cardiovascular Diseases, 2005
- Plasma lipid and lipoprotein concentrations in pregnancy induced hypertensionClinical Biochemistry, 2003
- Role of body mass index in the prediction of all cause mortality in over 62,000 men and women. The Italian RIFLE Pooling Project. Risk Factor and Life Expectancy.Journal of Epidemiology and Community Health, 1998
- Apolipoprotein A-I and B Levels and the Risk of Ischemic Heart Disease During a Five-Year Follow-up of Men in the Que´bec Cardiovascular StudyCirculation, 1996
- Hyperbetalipoproteinemia with small low-density lipoprotein, a characteristic disorder of lipoprotein in essential hypertensionJournal of Diabetes and its Complications, 1995
- Editor's introductory noteEuropean Heart Journal, 1988